Want to see HK:2327 full AI Analyst Report?
Top Page
Meilleure Health International Industry Group Limited
(2327)
Select Model
Select Model
Rating:47Neutral
Price Target:
HK$0.17
▼(-38.93% Downside)
Action:Reiterated
Date:10/17/26
The score is held down primarily by weak fundamentals (operating deterioration and especially negative/volatile cash flow) and bearish technicals (price below key moving averages with negative MACD). Valuation provides only partial support via a moderate P/E and a ~3.16% dividend yield.
Positive Factors
Moderate Leverage
Moderate leverage and a sizable equity base provide financial resilience relative to the company’s operating volatility. This structure can preserve flexibility to fund operations, manage downturns, and pursue opportunities without relying excessively on additional borrowing.
Negative Factors
Operating Deterioration
The operating loss shows that reported net income is not currently being supported by the core business engine. Persistent operating weakness can reduce financial quality, limit reinvestment capacity, and make future earnings more dependent on non-operating items rather than recurring activity.
Read all positive and negative factors
Positive Factors
Negative Factors
Moderate Leverage
Moderate leverage and a sizable equity base provide financial resilience relative to the company’s operating volatility. This structure can preserve flexibility to fund operations, manage downturns, and pursue opportunities without relying excessively on additional borrowing.
Read all positive factors
Meilleure Health International Industry Group Limited (2327) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$690.32M
Dividend Yield3.24%
Average Volume (3M)147.95K
Price to Earnings (P/E)13.5
Beta (1Y)0.21
Revenue Growth382.03%
EPS Growth31.25%
CountryHK
Employees43
SectorIndustrials
Sector Strength72
IndustryConglomerates
Share Statistics
EPS (TTM)0.01
Shares Outstanding4,060,684,600
10 Day Avg. Volume91,050
30 Day Avg. Volume147,950
Financial Highlights & Ratios
PEG Ratio1.61
Price to Book (P/B)0.86
Price to Sales (P/S)29.49
P/FCF Ratio-21.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Meilleure Health International Industry Group Limited Business Overview & Revenue Model
Company Description
Meilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include...
Meilleure Health International Industry Group Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
66
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 183.63M | 36.52M | 50.68M | 129.30M | 119.89M | 253.03M |
| Gross Profit | 36.93M | 22.63M | 28.91M | 78.09M | 66.76M | 100.93M |
| EBITDA | 2.10M | -8.61M | 56.52M | 71.38M | 55.46M | 108.73M |
| Net Income | 51.17M | 37.98M | 32.48M | 40.83M | 17.82M | 60.32M |
Balance Sheet | ||||||
| Total Assets | 1.79B | 1.82B | 1.67B | 1.70B | 1.71B | 1.74B |
| Cash, Cash Equivalents and Short-Term Investments | 10.86M | 20.18M | 29.94M | 106.31M | 210.99M | 380.39M |
| Total Debt | 291.39M | 380.96M | 303.06M | 297.06M | 249.13M | 170.42M |
| Total Liabilities | 483.04M | 567.34M | 467.29M | 442.89M | 384.18M | 306.35M |
| Stockholders Equity | 1.30B | 1.25B | 1.20B | 1.25B | 1.32B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | -28.34M | -50.60M | 188.62M | -137.32M | 42.10M | -89.79M |
| Operating Cash Flow | -28.34M | -50.02M | 188.75M | -136.49M | 43.15M | -83.27M |
| Investing Cash Flow | 122.64M | 14.64M | -253.98M | 53.72M | -134.76M | 161.56M |
| Financing Cash Flow | -96.84M | 18.07M | -6.39M | -18.90M | 41.93M | -38.22M |
Meilleure Health International Industry Group Limited Technical Analysis
Negative
0.28
Price Trends
0.22
Negative
0.23
Negative
0.25
Negative
Market Momentum
-0.01
Positive
24.58
Positive
60.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2327, the sentiment is Negative. The current price of 0.28 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.22, and above the 200-day MA of 0.25, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 24.58 is Positive, neither overbought nor oversold. The STOCH value of 60.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2327.
Meilleure Health International Industry Group Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$567.31M | 5.43 | 45.38% | ― | 18.31% | 37.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$1.36B | 3.24 | 4.37% | 6.67% | -11.27% | ― | |
52 Neutral | HK$185.77M | -13.70 | -4.03% | ― | -7.84% | -264.60% | |
51 Neutral | HK$1.28B | 3.04 | 81.64% | 1.20% | -57.48% | ― | |
47 Neutral | HK$690.32M | 13.49 | 4.01% | 3.24% | 382.03% | 31.25% | |
45 Neutral | HK$468.71M | -43.55 | 15.38% | ― | ― | ― |
* Industrials Sector Average
HK:2327
Meilleure Health International Industry Group Limited
0.17
-0.11
-38.85%
HK:8227
Xi'an Haitiantian Holdings Co
0.25
0.13
105.83%
HK:0025
Chevalier International Holdings Limited
4.50
0.86
23.66%
HK:0474
Aceso Life Science Group Limited
0.14
0.04
44.00%
HK:0689
EPI (Holdings) Limited
0.10
-0.02
-18.70%
HK:8162
Loco Hong Kong Holdings Ltd
0.57
-0.01
-1.72%
Meilleure Health International Industry Group Limited Corporate Events
Meilleure Health to Acquire Wholly Owned Subsidiary in Connected HK$35.2 Million Deal
Sep 21, 2026
Meilleure Health International Industry Group Limited has agreed to acquire the entire issued share capital of a target company for HK$35.2 million, using a wholly owned subsidiary as purchaser. Following completion, the target company will become...
Meilleure Health Declares Interim Cash Dividend for First Half of 2026
Aug 27, 2026
Meilleure Health International Industry Group Limited has declared an ordinary interim cash dividend of HKD 0.0015 per share for the six months ended 30 June 2026, for the financial year ending 31 December 2026. The move signals the board’s ...
Meilleure Health Profits Surge on Revenue Jump and JV Gains
Aug 27, 2026
Meilleure Health International Industry Group Limited reported a sharp increase in unaudited interim revenue to HK$164.6 million for the six months ended 30 June 2026, up from HK$17.5 million a year earlier, lifting gross profit to HK$28.5 million...
Meilleure Health Updates Bermuda Registered Office While Keeping Hong Kong Share Registrar
Jul 22, 2026
Meilleure Health International Industry Group Limited has announced that, with effect from 3 August 2026, its registered office and principal share registrar and transfer office in Bermuda will relocate to Richmond House, 12 Par-la-Ville Road, Ham...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.